Importantly, several lines have been authenticated and included in the LL-100 panel (ABC-DLBCL: NU-DHL-1, OCI-Ly3, Ri-1, U-2932, U-2946; GCB-DLBCL: DOHH-2, OCI-Ly7, OCI-LY19, SU-DHL-4, SU-DHL-6, and WSU-DLCL2). This evidence concerns the gene CD8B and diffuse large B-cell lymphoma.